HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sustained decreases in systemic blood pressure do not cause ocular hypotension.

Abstract
The unilateral, topical administration of certain ocular hypotensive agents, notably clonidine, is reported to result in a bilateral decrease in intraocular pressure. It has been previously proposed that such bilateral ocular hypotensive responses may be centrally mediated. However, the possible influence of blood pressure changes on intraocular pressure has remained a complicating factor in determining mechanisms of action. In order to further clarify the potential relationship between systemic blood pressure changes and intraocular pressure, the effects of two systemic antihypertensive drugs were determined in the conscious rabbit. Topical, unilateral administration of either hydralazine or prizidilol did not lower the intraocular pressure of either eye. A bolus intravenous injection of either hydralazine or prizidilol caused substantial systemic hypotension that persisted for at least 3 h, but no decreases in intraocular pressure occurred. These studies indicate that sustained decreases in systemic blood pressure of approximately 15 mm Hg do not result in ocular hypotension.
AuthorsD F Woodward, M C Dowling, J Chen, E Padillo, G Ruiz
JournalOphthalmic research (Ophthalmic Res) Vol. 21 Issue 1 Pg. 37-43 ( 1989) ISSN: 0030-3747 [Print] Switzerland
PMID2710496 (Publication Type: Journal Article)
Chemical References
  • Ophthalmic Solutions
  • Pyridazines
  • Vasodilator Agents
  • Hydralazine
  • prizidilol
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Female
  • Heart Rate (drug effects)
  • Hydralazine (pharmacology)
  • Injections, Intravenous
  • Intraocular Pressure (drug effects)
  • Male
  • Ophthalmic Solutions
  • Pyridazines (pharmacology)
  • Rabbits
  • Vasodilator Agents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: